| AAWH Stock | | | USD 0.37 0.03 7.50% |
Insider
Brian Miesieski is Chief Officer of Ascend Wellness Holdings
| Phone | 646 661 7600 |
| Web | https://www.awholdings.com |
Ascend Wellness Management Efficiency
Ascend Wellness' management efficiency ratios could be used to measure how well Ascend Wellness manages its routine affairs as well as how well it operates its assets and liabilities.
Ascend Wellness Holdings currently holds 230.85
M in liabilities with Debt to Equity
(D/E) ratio of 2.81, implying the company greatly
relies on financing operations through barrowing. Ascend Wellness Holdings has a current ratio of 2.09, suggesting that it is
liquid enough and is able to pay its financial obligations when due. Debt can assist Ascend Wellness until it has trouble settling it off, either with new capital or with free cash flow. So, Ascend Wellness' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Ascend Wellness Holdings sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Ascend to invest in growth at high rates of return. When we think about Ascend Wellness' use of debt, we should always consider it together with cash and equity.
Ascend Wellness Holdings, Inc. engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods. The company was incorporated in 2018 and is headquartered in New York, New York. Ascend Wellness operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 1800 people. Ascend Wellness Holdings [AAWH] is traded as part of a regulated electronic over-the-counter service offered by the NASD.
Management Performance
Ascend Wellness Holdings Leadership Team
Elected by the shareholders, the Ascend Wellness' board of directors comprises two types of representatives: Ascend Wellness inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ascend. The board's role is to monitor Ascend Wellness' management team and ensure that shareholders' interests are well served. Ascend Wellness' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ascend Wellness' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Francis Perullo, Interim CoFounder | |
| David Gacom, Chief Officer | |
| Brian Miesieski, Chief Officer | |
| Abner Kurtin, Founder Board | |
| Jason Liotta, VP Fin | |
| Daniel Neville, CFO, CoCEO | |
| Roman Nemchenko, VP Officer | |
| Robin Debiase, Chief Officer | |
| Christopher Melillo, Chief Officer | |
| Rebecca BSc, VP Relations | |
Ascend Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Ascend Wellness a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Currently Active Assets on Macroaxis
Other Information on Investing in Ascend OTC Stock
Ascend Wellness financial ratios help investors to determine whether Ascend OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ascend with respect to the benefits of owning Ascend Wellness security.